LIP
CBAY

Lighthouse Investment Partners’s Cymabay Therapeutics CBAY Stock Holding History

Lighthouse Investment Partners’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,092
Closed -$88K – 414
2023
Q1 		$88K Sell
10,092
-30,001
-75% -$240K 0.01% 237
2022
Q4 		$251K Buy
+40,093
New +$152K 0.03% 199

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Lighthouse Investment Partners's CBAY Position: Q2 2023 in Review

Lighthouse Investment Partners sold out of Cymabay Therapeutics (CBAY) in Q2 2023, closing a stake of 10,092 shares — an estimated $88K sold.

Lighthouse Investment Partners first reported a position in CBAY in Q4 2022 and held it in 2 quarters. The position peaked at $251K in Q4 2022. 151 funds tracked by Wall St. Rank hold CBAY as of Q2 2023.

  • Lighthouse Investment Partners reported no remaining Cymabay Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 10,092 Cymabay Therapeutics shares in Q2 2023, an estimated $88K.
  • Lighthouse Investment Partners first reported a position in Cymabay Therapeutics in Q4 2022 and held it in 2 quarters.
  • Lighthouse Investment Partners's Cymabay Therapeutics position peaked at $251K in Q4 2022.
  • 151 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2023.

Based on Lighthouse Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.